HCM
CELG

Holland Capital Management’s Celgene Corp CELG Stock Holding History

Holland Capital Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$36.7M Buy
282,878
+55,745
+25% +$6.83M 1.61% 25
2017
Q1 		$28.3M Buy
+227,133
New +$27.2M 1.21% 39

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Holland Capital Management's CELG Position: Q2 2017 in Review

Holland Capital Management increased its Celgene Corp (CELG) stake by 25% in Q2 2017, buying an estimated $6.83M and bringing the position to 282,878 shares worth $36.7M. The position accounts for 1.61% of the portfolio, ranked #25.

Holland Capital Management first reported a position in CELG in Q1 2017 and has held it in 2 quarters since. 1,428 funds tracked by Wall St. Rank hold CELG as of Q2 2017.

  • Holland Capital Management held 282,878 shares of Celgene Corp worth $36.7M as of Q2 2017.
  • Holland Capital Management bought 55,745 Celgene Corp shares in Q2 2017, an estimated $6.83M.
  • Celgene Corp made up 1.61% of Holland Capital Management's portfolio in Q2 2017, its #25 holding.
  • Holland Capital Management first reported a position in Celgene Corp in Q1 2017 and has held it in 2 quarters since.
  • 1,428 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2017.

Based on Holland Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.